600196 复星医药
已收盘 08-23 15:00:00
资讯
新帖
简况
复星医药: 在创新研发推进过程中,公司持续动态评估管线的市场价值
证券之星 · 08-21
复星医药: 在创新研发推进过程中,公司持续动态评估管线的市场价值
复星医药(02196)为控股子公司提供担保
智通财经 · 08-21
复星医药(02196)为控股子公司提供担保
复星医药08月21日主力资金流出358万元 连续7日减仓
自选股智能写手 · 08-21
复星医药08月21日主力资金流出358万元 连续7日减仓
仿制药一致性评价概念盘中跳水,复星医药跌1.16%
自选股智能写手 · 08-20
仿制药一致性评价概念盘中跳水,复星医药跌1.16%
新冠药物概念盘中跳水,复星医药跌1.03%
自选股智能写手 · 08-20
新冠药物概念盘中跳水,复星医药跌1.03%
细胞免疫治疗概念盘中跳水,复星医药跌0.69%
自选股智能写手 · 08-20
细胞免疫治疗概念盘中跳水,复星医药跌0.69%
单抗概念盘中跳水,复星医药跌0.60%
自选股智能写手 · 08-20
单抗概念盘中跳水,复星医药跌0.60%
专访复星医药全球研发中心CEO王兴利:医药格局重塑时代,本土药企如何追赶MNC?
21财经网 · 08-20
专访复星医药全球研发中心CEO王兴利:医药格局重塑时代,本土药企如何追赶MNC?
新质生产力引领 复星医药与未磁科技战略合作推动量子磁场传感技术高质量发展
大众证券报 · 08-19
新质生产力引领 复星医药与未磁科技战略合作推动量子磁场传感技术高质量发展
复星医药(02196)拟为控股子公司汉霖制药申请的3000万元的授信额度提供担保
智通财经 · 08-16
复星医药(02196)拟为控股子公司汉霖制药申请的3000万元的授信额度提供担保
Revance以9.24亿美元被收购!复星医药(600196.SH)在中国独家商业化其明星肉毒素产品
智通财经 · 08-16
Revance以9.24亿美元被收购!复星医药(600196.SH)在中国独家商业化其明星肉毒素产品
据报复星医药(02196.HK)等成立生物技术合伙企业 出资额100万元人币
阿斯达克财经 · 08-16
据报复星医药(02196.HK)等成立生物技术合伙企业 出资额100万元人币
减肥药概念盘中跳水,复星医药跌0.86%
自选股智能写手 · 08-16
减肥药概念盘中跳水,复星医药跌0.86%
北向资金8月15日净买入复星医药17.60万股 连续3日增持
自选股智能写手 · 08-16
北向资金8月15日净买入复星医药17.60万股 连续3日增持
8月15日复星医药现1笔大宗交易 机构净卖出2776.19万元
证券之星 · 08-15
8月15日复星医药现1笔大宗交易 机构净卖出2776.19万元
复星医药:斯鲁利单抗注射液上市许可申请获EMA收礼,目前处于审评阶段
每日经济新闻 · 08-15
复星医药:斯鲁利单抗注射液上市许可申请获EMA收礼,目前处于审评阶段
对话复星康养总裁陈育骏:养老设施REITs发行的“任督二脉”已打通
中新经纬 · 08-15
对话复星康养总裁陈育骏:养老设施REITs发行的“任督二脉”已打通
复星医药08月15日主力资金流出115万元 连续3日减仓
自选股智能写手 · 08-15
复星医药08月15日主力资金流出115万元 连续3日减仓
复星康养入选“2024年度影响力康养产业综合运营企业”
观点新媒体 · 08-15
复星康养入选“2024年度影响力康养产业综合运营企业”
复星医药(02196)新增募集资金专户并签订募集资金专户存储三方监管协议
智通财经网 · 08-13
复星医药(02196)新增募集资金专户并签订募集资金专户存储三方监管协议
公司概况
公司名称:
上海复星医药(集团)股份有限公司
所属行业:
医药制造业
上市日期:
1998-08-07
主营业务:
上海复星医药(集团)股份有限公司主营业务是制药、医疗器械、医学诊断、医疗健康服务。主要产品为心血管系统疾病治疗领域核心产品、中枢神经系统疾病治疗领域核心产品、血液系统疾病治疗领域核心产品、代谢及消化系统疾病治疗领域核心产品、抗感染疾病治疗领域核心产品、抗肿瘤治疗领域核心产品、原料药和中间体核心产品。根据中华人民共和国工信部中国医药工业信息中心颁布的2018年度中国医药工业百强企业榜单,本集团位列第7。由米内研究院主办的“中国医药工业百强系列榜单”,本集团成功入选“2022年度中国化药企业TOP100排行榜”,位列中国化药企业百强榜第6位;根据IQVIA统计,2023年第一季度本集团的医院用处方药销售收入位列全国第12位;根据全球医药智库信息平台InformaPharmaIntelligence发布的《2023年医药研发趋势年度分析》白皮书,本集团再次入选“全球医药企业研发管线规模Top25”。
发行价格:
7.15
{"stockData":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"复星医药","latestPrice":22.4,"timestamp":1724396400000,"preClose":22.39,"halted":0,"volume":5102954,"delay":0,"floatShares":2118000000,"shares":2672000000,"eps":0.7518,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"08-23 15:00:00","open":22.44,"high":22.56,"low":22.3,"amount":114000000,"amplitude":0.0116,"askPrice":22.41,"askSize":353,"bidPrice":22.4,"bidSize":43,"shortable":0,"etf":0,"ttmEps":0.7518,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":22.39,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":24.63,"lowLimit":20.15,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2672398711,"pbRate":1.29,"roa":"--","roe":"1.33%","epsLYR":0.89,"committee":-0.267974,"marketValue":59862000000,"floatMarketCap":47454000000,"peRate":29.795158,"changeRate":0.0004,"turnoverRate":0.0024,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-26。"},"requestUrl":"/m/hq/s/600196/wiki","defaultTab":"wiki","newsList":[{"id":"2461472849","title":"复星医药:\n在创新研发推进过程中,公司持续动态评估管线的市场价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2461472849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461472849?lang=zh_cn&edition=full","pubTime":"2024-08-21 19:01","pubTimestamp":1724238083,"startTime":"0","endTime":"0","summary":"证券之星消息,复星医药(600196)08月21日在投资者关系平台上答复投资者关心的问题。投资者:请介绍一下从Palatin公司授权的“女伟哥”bremelantide临床进展情况?复星医药董秘:投资者您好!在创新研发推进过程中,公司持续动态评估管线的市场价值。基于流行病学调研、临床需求差异等综合因素,已决策终止该项目。感谢您对公司的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082100034039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0187","BK0028","BK1593","BK0196","BK0060","BK0188","02196","BK1191","BK0239","BK0183","BK1515","BK0012","600196","BK0096"],"gpt_icon":0},{"id":"2461527845","title":"复星医药(02196)为控股子公司提供担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2461527845","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461527845?lang=zh_cn&edition=full","pubTime":"2024-08-21 18:29","pubTimestamp":1724236141,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(02196)发布公告,公司拟为控股子公司朝晖药业向广发银行申请的本金不超过人民币2000万元的融资项下债务提供最高额连带责任保证担保;控股子公司北京卫驰拟为其控股子公司北京北铃向北京银行申请的人民币500万元贷款提供连带责任保证担保;公司、控股子公司复星健康拟为共同向华美银行申请的等值1500万美元共享授信额度项下债务互负连带清偿责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1167799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK1515","BK0196","BK0239","BK0096","BK1593","BK0028","BK0175","BK1191","BK0060","02196","600196","BK0188","BK0187","BK0183"],"gpt_icon":0},{"id":"2461900518","title":"复星医药08月21日主力资金流出358万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2461900518","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461900518?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:17","pubTimestamp":1724224646,"startTime":"0","endTime":"0","summary":"08月21日, 复星医药股价跌1.26%,报收22.77元,成交金额1.18亿元,换手率0.24%,振幅1.65%,量比0.75。复星医药今日主力资金净流出358万元,连续7日净流出,上一交易日主力净流出1773万元,今日环比减少79.81%。该股近5个交易日下跌2.44%,主力资金累计净流出3093万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1.74亿元,其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211520079f40f344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408211520079f40f344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0028","BK0175","BK0012","BK0187","BK0239","600196","BK0188","BK0060","BK0183","BK0196"],"gpt_icon":0},{"id":"2460478045","title":"仿制药一致性评价概念盘中跳水,复星医药跌1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460478045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460478045?lang=zh_cn&edition=full","pubTime":"2024-08-20 13:10","pubTimestamp":1724130612,"startTime":"0","endTime":"0","summary":"08月20日,仿制药一致性评价概念盘中跳水,截至13点10分,仿制药一致性评价概念整体指数下跌2.01%,报845.580点。从个股上来看,该概念的成分股中,复星医药跌1.16%,华海药业、京新药业、福元医药跌幅居前。从资金上来看,截止发稿,仿制药一致性评价概念主力净流入为-3.55亿,其中海辰药业受到资金热捧,主力净流入1119.09万;拉长时间线来看,该板块近20日主力资金净流入-38.27亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820131012af97804a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820131012af97804a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","600196","BK1593"],"gpt_icon":0},{"id":"2460045934","title":"新冠药物概念盘中跳水,复星医药跌1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460045934","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460045934?lang=zh_cn&edition=full","pubTime":"2024-08-20 13:02","pubTimestamp":1724130168,"startTime":"0","endTime":"0","summary":"08月20日,新冠药物概念盘中跳水,截至13点02分,新冠药物概念整体指数下跌2.04%,报459.620点。从个股上来看,该概念的成分股中,复星医药跌1.03%,华海药业、科兴制药、泰恩康跌幅居前。从资金上来看,截止发稿,新冠药物概念主力净流入为-2.47亿,其中诺泰生物受到资金热捧,主力净流入1381.12万;拉长时间线来看,该板块近20日主力资金净流入-29.43亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820130248af978030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820130248af978030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0187","BK0196","BK0188","BK0028","600196","BK0183","BK0239","BK0096","BK0012","BK0175"],"gpt_icon":0},{"id":"2460238016","title":"细胞免疫治疗概念盘中跳水,复星医药跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460238016","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460238016?lang=zh_cn&edition=full","pubTime":"2024-08-20 10:19","pubTimestamp":1724120379,"startTime":"0","endTime":"0","summary":"08月20日,细胞免疫治疗概念盘中跳水,截至10点19分,细胞免疫治疗概念整体指数下跌1.04%,报671.070点。从个股上来看,该概念的成分股中,复星医药跌0.69%,ST八菱、东北制药、国际医学跌幅居前。从资金上来看,截止发稿,细胞免疫治疗概念主力净流入为-8294.94万,其中达安基因受到资金热捧,主力净流入5986.73万;拉长时间线来看,该板块近20日主力资金净流入-31.51亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820101939af977faa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820101939af977faa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","600196","BK1515","BK1191","BK1574","02196","06978"],"gpt_icon":0},{"id":"2460501634","title":"单抗概念盘中跳水,复星医药跌0.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460501634","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460501634?lang=zh_cn&edition=full","pubTime":"2024-08-20 10:06","pubTimestamp":1724119583,"startTime":"0","endTime":"0","summary":"08月20日,单抗概念盘中跳水,截至10点06分,单抗概念整体指数下跌1.01%,报1675.780点。从个股上来看,该概念的成分股中,复星医药跌0.60%,丽珠集团、桂林三金、百济神州-U跌幅居前。从资金上来看,截止发稿,单抗概念概念主力净流入为-1.03亿,其中康弘药业受到资金热捧,主力净流入930.21万;拉长时间线来看,该板块近20日主力资金净流入-19.98亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820100623aefedb6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820100623aefedb6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1515","600196","BK1191","BK1593"],"gpt_icon":0},{"id":"2460343016","title":"专访复星医药全球研发中心CEO王兴利:医药格局重塑时代,本土药企如何追赶MNC?","url":"https://stock-news.laohu8.com/highlight/detail?id=2460343016","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460343016?lang=zh_cn&edition=full","pubTime":"2024-08-20 10:01","pubTimestamp":1724119279,"startTime":"0","endTime":"0","summary":"复星医药执行总裁、全球研发中心CEO王兴利在接受21世纪经济报道记者采访时表示,“老牌药企大部分都是仿制药出身,向创新药企转型需要一个迭代的过程。虽然时间可能会比较长,但我国本土药企中未来一定有能成长为国际化的跨国药企。”复星医药执行总裁、全球研发中心CEO王兴利选择合适的创新策略创新药的研发历来具有高风险高投入的特性。此外,复星医药还采用合作开发的模式,落地了中国首款CAR-T细胞治疗产品奕凯达。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201001299f3bdb71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201001299f3bdb71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","09939","BK1604","LU0052750758.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU0067412154.USD","LU0231483743.USD","LU0106252389.USD","LU0048597586.USD","LU0359201885.HKD","LU0029875118.USD","LU0164865239.USD","LU0149721374.USD","LU0128522157.USD","BK1161","LU0449509016.USD","LU0449515922.USD","LU0320764755.SGD","BK1591","LU0348788117.USD","IE00B543WZ88.USD","LU0431992006.USD","IE0034224299.USD","LU0269904917.USD","LU0054450605.USD","LU0348816934.USD","LU0348805143.USD","IE0032431581.USD","LU0051755006.USD","LU0043850808.USD","LU0049853897.USD","LU0164880469.USD","600196","LU0359202008.SGD","LU0320764599.SGD","02196","BK1142","LU0211977185.USD","BK1574","BK1521","LU0251144936.SGD","LU0348735423.USD","BK1589","LU0315178854.USD","LU0348814723.USD","LU0359201612.USD","BK1233","LU0417516738.SGD","LU0048580855.USD"],"gpt_icon":1},{"id":"2460408439","title":"新质生产力引领 复星医药与未磁科技战略合作推动量子磁场传感技术高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2460408439","media":"大众证券报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460408439?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:39","pubTimestamp":1724063940,"startTime":"0","endTime":"0","summary":"8月18日上午,国家重点研发计划“新型无液氦脑磁图系统研发”成果发布会暨未磁科技与复星医疗器械战略合作签约仪式在北京中关村国际创新中心成功举办。复星医疗器械与未磁科技正式启动战略合作,双方强强联合,有望推动量子磁场传感技术在脑科学研究和脑疾病诊疗中的应用与落地,成为重大脑疾病的精准诊疗整体解决方案,造福于广大患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408191840559f39980e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408191840559f39980e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0187","BK0239","BK0196","BK0175","BK0183","BK0012","BK0060","BK0028","BK0188","00656","600196","02196"],"gpt_icon":0},{"id":"2459291502","title":"复星医药(02196)拟为控股子公司汉霖制药申请的3000万元的授信额度提供担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2459291502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459291502?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:19","pubTimestamp":1723803579,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(02196)发布公告,2024年8月16日,公司控股子公司上海复宏汉霖生物制药有限公司(“汉霖制药”)与南京银行股份有限公司上海分行(“南京银行”)签订《最高债权额度合同》,汉霖制药向南京银行申请人民币3000万元的授信额度,授信额度项下债务发生期间为2024年6月21日至2025年6月20日。同日,控股子公司上海复宏汉霖生物技术股份有限公司(系汉霖制药的直接控股股东,以下简称“复宏汉霖”)与南京银行签订《最高额保证合同》,由复宏汉霖为汉霖制药于上述授信额度项下债务提供最高额连带责任保证担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","BK0239","BK0096","BK0183","01477","BK0028","BK0012","BK0188","BK1593","02196","BK1574","BK0187","BK0175","BK0196","BK1515","BK0060","BK1191"],"gpt_icon":0},{"id":"2459267799","title":"Revance以9.24亿美元被收购!复星医药(600196.SH)在中国独家商业化其明星肉毒素产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2459267799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459267799?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:46","pubTimestamp":1723798008,"startTime":"0","endTime":"0","summary":"近日,一桩近10亿美元的收购案引发全球医美行业关注,8月13日,Crown Laboratories宣布将以9.24亿美元现金收购明星企业Revance Therapeutics, Inc. ,收购价为每股6.66美元,较2024年8月9日收盘价溢价89%,较60天VWAP溢价111%。作为一家新兴的生物科技公司,Revance凭借其创新的长效肉毒素产品DAXXIFY进入市场,引发了业界的广泛关注。在中国,复星医药早在2018年就已经和Revance达成合作,成为对方在中国的独家商业化合作伙伴。2022年9月,Revance作为美国第五款获批肉毒素上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0187","BK0239","BK1515","BK0196","BK0175","BK0183","BK0012","BK0060","BK0028","BK0188","BK1191","BK1593","600196","02196"],"gpt_icon":0},{"id":"2459572702","title":"据报复星医药(02196.HK)等成立生物技术合伙企业 出资额100万元人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2459572702","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459572702?lang=zh_cn&edition=full","pubTime":"2024-08-16 13:54","pubTimestamp":1723787640,"startTime":"0","endTime":"0","summary":"据内媒报道,成都金诚安生物技术合伙企业(有限合伙)于近日成立,由复星医药(02196.HK) 旗下上海复星平耀投资管理及战兴泽共同持股,出资额为100万元人民币。新公司的经营范围包括技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广、企业管理咨询。(js/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-16 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174702240_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174702240_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1372274&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0196","BK0012","BK0183","BK0239","BK0028","600196","BK0188","BK0175","02196","BK0096","BK1515","BK1593","BK0187","BK0060","BK1191"],"gpt_icon":0},{"id":"2459239660","title":"减肥药概念盘中跳水,复星医药跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459239660","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459239660?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:36","pubTimestamp":1723772205,"startTime":"0","endTime":"0","summary":"08月16日,减肥药概念盘中跳水,截至09点36分,减肥药概念整体指数下跌0.54%,报789.920点。从个股上来看,该概念的成分股中,复星医药跌0.86%,信立泰、爱美客、诺泰生物跌幅居前。从资金上来看,截止发稿,减肥药概念主力净流入为489.45万,其中华东医药受到资金热捧,主力净流入593.87万;拉长时间线来看,该板块近20日主力资金净流入-18.37亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093645968267e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093645968267e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","600196","BK1515","BK1593"],"gpt_icon":0},{"id":"2459191236","title":"北向资金8月15日净买入复星医药17.60万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459191236","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459191236?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771808,"startTime":"0","endTime":"0","summary":"8月15日, 北向资金增持复星医药17.60万股,连续3日增持。截止当日收盘,沪股通共持有复星医药5883.18万股,占流通股2.77%。沪股通增持金额前五个股分别为中国平安、招商银行、中信证券、贵州茅台、拓普集团。复星医药近5个交易日下跌1.60%,沪股通累计减持28.69万股;近20个交易日上涨0.78%,沪股通累计增持354.74万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093034959cede5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093034959cede5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK1593","02196","BK1515","BK1191"],"gpt_icon":0},{"id":"2459443891","title":"8月15日复星医药现1笔大宗交易 机构净卖出2776.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459443891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459443891?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:20","pubTimestamp":1723713637,"startTime":"0","endTime":"0","summary":"证券之星消息,8月15日复星医药发生大宗交易,交易数据如下:大宗交易成交价格23.32元,成交119.05万股,成交金额2776.19万元,买方营业部为中国中金财富证券有限公司山东分公司,卖方营业部为机构专用。近三个月该股共发生1笔大宗交易,合计成交1.19万手。该股近期无解禁股上市。截至2024年8月15日收盘,复星医药报收于23.32元,下跌0.09%,换手率0.36%,成交量7.58万手,成交额1.77亿元。该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500035533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0196","BK0175","BK0060","BK0188","BK0183","BK1191","02196","BK1515","600196","BK0012","BK0239","BK0096","BK1593","BK0028"],"gpt_icon":0},{"id":"2459448356","title":"复星医药:斯鲁利单抗注射液上市许可申请获EMA收礼,目前处于审评阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2459448356","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459448356?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:03","pubTimestamp":1723712592,"startTime":"0","endTime":"0","summary":"至今过去一年多,进展如何,请问在三季度能获批吗?复星医药8月15日在投资者互动平台表示,斯鲁利单抗注射液联合化疗一线治疗广泛期小细胞肺癌的上市许可申请于2023年3月获得欧洲药品管理局受理,目前处于审评阶段,获得上市许可的时间和结果均具有不确定性。公司将持续推进该产品的全球商业化布局,提升产品的可及性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815170358959aefd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815170358959aefd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0187","BK0028","BK0012","BK0060","BK0188","BK0239","BK0183","BK0096","600196","BK0196"],"gpt_icon":0},{"id":"2459448353","title":"对话复星康养总裁陈育骏:养老设施REITs发行的“任督二脉”已打通","url":"https://stock-news.laohu8.com/highlight/detail?id=2459448353","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459448353?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:28","pubTimestamp":1723710498,"startTime":"0","endTime":"0","summary":"在2024博鳌房地产论坛上,复星康养产业发展集团总裁陈育骏对中新经纬说:“这是打通了发行养老设施REITs的‘任督二脉’,让有重资产的养老公司能够实现资本回收。”国家发展改革委于今年7月底发布的《基础设施领域不动产投资信托基金项目申报要求》中,将养老设施纳入REITs发行之中。目前,市场上还没有以养老设施为底层资产的REITs产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815171053959af954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815171053959af954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00656","BK0239","BK0060","02196","BK0175","BK0196","600196","BK0028","BK0188","BK0012","BK0183","BK0096","BK0187"],"gpt_icon":0},{"id":"2459741620","title":"复星医药08月15日主力资金流出115万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2459741620","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459741620?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:18","pubTimestamp":1723706292,"startTime":"0","endTime":"0","summary":"08月15日, 复星医药股价跌0.09%,报收23.32元,成交金额1.77亿元,换手率0.36%,振幅1.54%,量比0.74。复星医药今日主力资金净流出115万元,连续3日净流出,上一交易日主力净流出2370万元,今日环比减少95.15%。该股近5个交易日下跌1.60%,主力资金累计净流出4305万元;近20日主力资金累计净流出2.08亿元,其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815152658959a9a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815152658959a9a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0060","BK0012","BK0175","BK0028","BK0239","BK0183","BK0187","600196","BK0188","BK0196"],"gpt_icon":0},{"id":"2459468575","title":"复星康养入选“2024年度影响力康养产业综合运营企业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2459468575","media":"观点新媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459468575?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:27","pubTimestamp":1723685231,"startTime":"0","endTime":"0","summary":"8月14日晚,我们一同见证并祝贺复星康养入选“2024年度影响力康养产业综合运营企业”,复星星堡中环养老公寓入选“2024年度影响力品质康养社区”。复星康养获颁发“2024年度影响力康养产业综合运营企业”关于观点指数观点指数研究院是观点机构旗下数据研究部门,长期跟踪经济走势、行业动态、企业表现,捕捉全面、深入的市场和企业数据,并结合专业分析,生产原创、深度的研究报告,输出专业权威的研究成果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150944179f2c101d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150944179f2c101d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1230","02196","00656","600196"],"gpt_icon":0},{"id":"2459978090","title":"复星医药(02196)新增募集资金专户并签订募集资金专户存储三方监管协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2459978090","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459978090?lang=zh_cn&edition=full","pubTime":"2024-08-13 17:50","pubTimestamp":1723542607,"startTime":"0","endTime":"0","summary":"复星医药(02196)发布公告,近日,复星医药(徐州)、复星医药(深圳)已分别于相...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_16.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_16.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0060","BK0012","02196","BK0175","BK0183","BK0188","BK0196","BK1515","600196","BK0187","BK1191","BK0096","BK0028","BK0239","BK1593"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1998-08-07","address":"上海市普陀区曹杨路510号9楼","stockEarnings":[{"period":"1week","weight":-0.0448},{"period":"1month","weight":-0.0062},{"period":"3month","weight":-0.019},{"period":"6month","weight":-0.0586},{"period":"1year","weight":-0.1858},{"period":"ytd","weight":-0.0947}],"companyName":"上海复星医药(集团)股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"267239万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 上海复星医药(集团)股份有限公司主营业务是制药、医疗器械、医学诊断、医疗健康服务。主要产品为心血管系统疾病治疗领域核心产品、中枢神经系统疾病治疗领域核心产品、血液系统疾病治疗领域核心产品、代谢及消化系统疾病治疗领域核心产品、抗感染疾病治疗领域核心产品、抗肿瘤治疗领域核心产品、原料药和中间体核心产品。根据中华人民共和国工信部中国医药工业信息中心颁布的2018年度中国医药工业百强企业榜单,本集团位列第7。由米内研究院主办的“中国医药工业百强系列榜单”,本集团成功入选“2022年度中国化药企业TOP100排行榜”,位列中国化药企业百强榜第6位;根据IQVIA统计,2023年第一季度本集团的医院用处方药销售收入位列全国第12位;根据全球医药智库信息平台InformaPharmaIntelligence发布的《2023年医药研发趋势年度分析》白皮书,本集团再次入选“全球医药企业研发管线规模Top25”。","serverTime":1724555429183,"listedPrice":7.15,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复星医药(600196)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复星医药(600196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复星医药,600196,复星医药股票,复星医药股票老虎,复星医药股票老虎国际,复星医药行情,复星医药股票行情,复星医药股价,复星医药股市,复星医药股票价格,复星医药股票交易,复星医药股票购买,复星医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复星医药(600196)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复星医药(600196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}